KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Short term Debt (2016 - 2025)

Historic Short term Debt for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $299.0 million.

  • Boston Scientific's Short term Debt fell 8318.34% to $299.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $299.0 million, marking a year-over-year decrease of 8318.34%. This contributed to the annual value of $299.0 million for FY2025, which is 8318.34% down from last year.
  • Per Boston Scientific's latest filing, its Short term Debt stood at $299.0 million for Q4 2025, which was down 8318.34% from $483.0 million recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Short term Debt registered a high of $1.8 billion during Q4 2024, and its lowest value of $13.0 million during Q1 2021.
  • Its 5-year average for Short term Debt is $574.6 million, with a median of $481.5 million in 2025.
  • Its Short term Debt has fluctuated over the past 5 years, first plummeted by 9870.52% in 2021, then skyrocketed by 255500.0% in 2023.
  • Boston Scientific's Short term Debt (Quarter) stood at $261.0 million in 2021, then plummeted by 92.34% to $20.0 million in 2022, then surged by 2555.0% to $531.0 million in 2023, then soared by 234.84% to $1.8 billion in 2024, then plummeted by 83.18% to $299.0 million in 2025.
  • Its Short term Debt was $299.0 million in Q4 2025, compared to $483.0 million in Q3 2025 and $480.0 million in Q2 2025.